Boca Raton, FLNCT05516004Now EnrollingIRB Ready

Keratoconus Clinical Trial in Boca Raton, FL

Access cutting-edge keratoconus treatment through this phase 2 clinical trial at a research site in Boca Raton. Study-provided care at no cost to qualified participants.

Sponsored by Cohen Laser and Vision Center

Quick Self-Assessment

See if you qualify for this Boca Raton location

Preparing your pre-screening questions…

Expert Care in Boca Raton

Access keratoconus specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related keratoconus treatment provided free

Apply for This Boca Raton Location

Check if you qualify for this keratoconus clinical trial in Boca Raton, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boca Raton

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boca Raton site if eligible
  4. 4Begin participation

About This Keratoconus Study in Boca Raton

This study study is to determine the effectiveness of cornea cross linking in patients with Keratoconus or other cornea thinning conditions.

Sponsor: Cohen Laser and Vision Center

Who Can Participate

Inclusion Criteria

healthy subjects with no other medical or ocular conditions Subjects who have one or both eyes that meet criteria 1 and 1 or more of the following criteria will be considered candidates for this study:
18 years of age or older
Presence of central or inferior steepening (on Pentacam topograph)
Axial topography consistent with keratoconus, post-surgical ectasia, or pellucid marginal degeneration (See keratoconus grading section 7.0 for details)
Presence of one or more findings associated with keratoconus or pellucid marginal degeneration on slit lamp exam such as:
Fleischer ring
Vogt's striae
Decentered corneal apex
Munson's sign
Rizzutti's sign
Apical Corneal scarring consistent with Bowman's breaks
Scissoring of the retinoscopic reflex
Crab-claw appearance on topography
Steepest keratometry (Kmax) value ≥ 47.20 D on simK or Pentacam
I-S keratometry difference \> 1.5 D on the Pentacam/Galilei/Orbscan/Cassini map or topography map
Posterior corneal elevation \>16 microns (µm on Pentacam tomography)
Thinnest corneal point \<485 microns (ultrasound pachymetry or Pentacam tomography)
Predicted Post LASIK/PRK stromal ablation depth \<350 microns or expected keratometry \>47.2 D, or patients undergoing PRK/SMILE in keratoconus suspect eyes
Bacterial or fungal corneal keratitis persistent and not responding despite \> 2 weeks of standard antimicrobial therapy or with rapid progression of corneal thinning, with loss of \>25% corneal thickness
Contact Lens Wearers Only:
Removal of contact lenses for the required period of time prior to the screening refraction: Contact Lens Type Minimum Discontinuation Time Soft 1 Week Soft Extended Wear 2 Weeks Soft Toric 3 Weeks Rigid gas permeable 2 Weeks per decade of wear
Signed written informed consent
Willingness and ability to comply with schedule for follow-up visits

Exclusion Criteria

active infections, collagen vascular disease, allergic to product All subjects meeting any of the following criteria will be excluded from this study:
Eyes classified as either normal or atypical normal on the severity grading scheme.
Corneal pachymetry at the screening exam that is \<300 microns at the thinnest point in the eye(s) to be treated.
Previous ocular condition (other than refractive error) in the eye(s) to be treated that may predispose the eye for future complications, for example:
History of or active corneal disease (e.g., herpes simplex, herpes zoster keratitis, recurrent erosion syndrome, acanthomeoeba, etc.)
Clinically significant corneal scarring in the CXL treatment zone that is not related to keratoconus or, in the investigator's opinion, will interfere with the cross-linking procedure.
Pregnancy (including plan to become pregnant) or lactation during the course of the study
A known sensitivity to study medications
Patients with cognitive or ambulatory conditions that would prevent eye drop compliance with medications
Patients with nystagmus or any other condition that would prevent a steady gaze during the CXL treatment or other diagnostic tests.
Patients with a current condition that, in the physician's opinion, would interfere with or prolong epithelial healing.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boca Raton?

Yes, this clinical trial (NCT05516004) has an active research site in Boca Raton, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Keratoconus Treatment Options in Boca Raton, FL

If you're searching for keratoconus treatment options in Boca Raton, FL, this clinical trial (NCT05516004) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boca Raton research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced keratoconus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all keratoconus clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Boca Raton, FL

See all rheumatoid arthritis clinical trials recruiting in Boca Raton — not just this study.

Browse Rheumatoid Arthritis Trials in Boca Raton →

Ready to Join in Boca Raton?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boca Raton, FL